Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Metastasis
Clinical trial NCT05661110 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05661110
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-01
- Primary completion
- 2025-03-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.